UPDATE: UBS Securities Downgrades Calpine on Concerns About Texas and California
In a report published Wednesday, UBS Securities analyst Julien Dumoulin-Smith downgraded the rating on Calpine (NYSE: CPN) from Buy to Neutral, but reiterated the $22.00 price target.
In the report, UBS Securities noted, “We're downgrading shares to Neutral from Buy following its latest move, and our concerns around TX (Guadalupe being potentially dilutive to '15 multiple) and CA. While developments in the Northeast are constructive, we see its more limited footprint and exposure to upcoming PJM capacity auction in (E)MAAC as less than ideal.”
Calpine closed on Tuesday at $20.44.
Latest Ratings for CPN
|May 2016||SunTrust Robinson Humphrey||Maintains||Neutral|
|Mar 2016||Argus Research||Downgrades||Buy||Hold|
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.